What HHS's Schedule III Recommendation Could Mean and What Comes Next
Leading legal experts will discuss the Department of Health and Human Services’ recommendation to the Drug Enforcement Agency to reschedule cannabis to Schedule III, what its potential implications could be for the industry and the legalization movement, and what still needs to happen before rescheduling becomes a reality.
Valuation in Cannabis M&A,
With Thoughts on Restructuring
October 24th, 2023 | 12pm EST/11am CST/9am PST
This CLE-accredited live webinar will address strategies for handling valuation disputes and other post-closing adjustments arising from cannabis M&A, looking at before-the-fact transactional considerations and after-the-fact litigation solutions. We will also consider the availability of state-law restructuring and turnaround remedies given the absence of federal bankruptcy protection for cannabis companies.
The event production facility has been moved to a secure location.https://production.incbaevents.orgFor login instructions, please reach out to the person who invited you to participate in the session.If you still require assistance, please email: email@example.com